Astellas Pharma (4503N) Q3 2022 Earnings Report
1 Followers
MX:4503N Q3 2022 EPS Results
- Actual EPS
- MXN 3.12
- Consensus EPS
- MXN 4.61
- Beat/Miss
- Missed by -MXN 1.49
- One Year Ago EPS
- MXN 3.86
MX:4503N Q3 2022 Revenue Results
- Actual Revenue
- MXN 47.26B
- Expected Revenue
- MXN 45.77B
- Beat/Miss
- Beat by +MXN 1.49B
- YoY Revenue Growth
- +18.07%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 02/06/2023
- Time
- Before Open
- Conference Call
- Monday, February 6, 2023
MX:4503N Upcoming Earnings
Astellas Pharma's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
MX:4503N Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2026 (Q3) | 7.05- | 6.59 | ― | ― |
| Nov 04, 2026 | 2026 (Q2) | 7.646.54 | 5.2 | 25.92% (+1.35) | |
| Aug 05, 2026 | 2026 (Q1) | 6.369.30 | 4.49 | 107.09% (+4.81) | |
| Apr 27, 2026 | 2025 (Q4) | 3.592.85 | 4.92 | -41.95% (-2.06) | |
| Feb 04, 2026 | 2025 (Q3) | 5.406.59 | -6.41 | 202.73% (+13.00) | |
| Oct 30, 2025 | 2025 (Q2) | 3.505.20 | 2.36 | 120.44% (+2.84) | |
| Jul 30, 2025 | 2025 (Q1) | 2.344.49 | 2.47 | 82.00% (+2.02) | |
| Apr 25, 2025 | 2024 (Q4) | 2.504.92 | -2.18 | 325.50% (+7.10) | |
| Feb 04, 2025 | 2024 (Q3) | 2.88-6.41 | 1.22 | -624.52% (-7.63) | |
| Oct 30, 2024 | 2024 (Q2) | 2.122.36 | -0.09 | 2607.50% (+2.45) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
